APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.

BACKGROUND: The APOE genotype predicts the age at onset of Alzheimer disease (AD) and neuropathologic progression. However, studies relating APOE alleles to the rate of cognitive decline have been inconclusive. This may stem from their use of linear statistical analyses. OBJECTIVE: To model relation...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Martins, C, Oulhaj, A, de Jager, C, Williams, J
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2005

Παρόμοια τεκμήρια

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
ανά: Oulhaj, A, κ.ά.
Έκδοση: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
ανά: Oulhaj, A, κ.ά.
Έκδοση: (2010)

An increased rate of longitudinal cognitive decline is observed in Parkinson's disease patients with low CSF Aß42 and an APOE ε4 allele
ανά: Marian Shahid, κ.ά.
Έκδοση: (2019-07-01)

Disentangling sex-dependent effects of APOE on diverse trajectories of cognitive decline in Alzheimer's disease
ανά: Haixu Ma, κ.ά.
Έκδοση: (2024-04-01)

Cognitive declines precede and predict functional declines in aging and Alzheimer's disease.
ανά: Laura B Zahodne, κ.ά.
Έκδοση: (2013-01-01)

Protective effect of the APOE-e3 allele in Alzheimer’s disease
ανά: B.V.P. de-Almada, κ.ά.
Έκδοση: (2012-01-01)

Effect of apolipoprotein E ε4 allele on the progression of cognitive decline in the early stage of Alzheimer's disease
ανά: Kazushi Suzuki, κ.ά.
Έκδοση: (2020-01-01)

Protective effect of the APOE-e3 allele in Alzheimer’s disease
ανά: B.V.P. de-Almada, κ.ά.
Έκδοση: (2012-01-01)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
ανά: Oulhaj, A, κ.ά.
Έκδοση: (2016)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
ανά: Holmes, C, κ.ά.
Έκδοση: (2005)

Amyloid-β and APOE genotype predict memory decline in cognitively unimpaired older individuals independently of Alzheimer’s disease polygenic risk score
ανά: Jori Tomassen, κ.ά.
Έκδοση: (2022-12-01)

Predictive Factors of Rapid Cognitive Decline in Patients with Alzheimer Disease
ανά: Coralie Barbe, κ.ά.
Έκδοση: (2016-12-01)

Periodontitis and Cognitive Decline in Alzheimer's Disease.
ανά: Mark Ide, κ.ά.
Έκδοση: (2016-01-01)

Neuroticism alters the transcriptome of the frontal cortex to contribute to the cognitive decline and onset of Alzheimer’s disease
ανά: Céline H. De Jager, κ.ά.
Έκδοση: (2021-02-01)

Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease
ανά: Allen, G, κ.ά.
Έκδοση: (2016)

APOE GENE POLYMORPHISM: THE IMPACT OF APOE4 ALLELE ON SYSTEMIC INFLAMMATION AND ITS ROLE IN THE PATHOGENESIS OF ALZHEIMER’S DISEASE
ανά: I. K. Malashenkova, κ.ά.
Έκδοση: (2018-06-01)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
ανά: Pia Kivisäkk, κ.ά.
Έκδοση: (2023-03-01)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
ανά: Hákon Valur Dansson, κ.ά.
Έκδοση: (2021-09-01)

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.
ανά: Lai, M, κ.ά.
Έκδοση: (2002)

Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
ανά: Nicholas C. Cullen, κ.ά.
Έκδοση: (2021-06-01)

APOE epsilon 4 allele affects presynaptic, but not postsynaptic cholinergic markers in Alzheimer's disease neocortex
ανά: Lai, M, κ.ά.
Έκδοση: (2006)

Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
ανά: Lai, M, κ.ά.
Έκδοση: (2006)

A TOMM40/APOE allele encoding APOE‐E3 predicts high likelihood of late‐onset Alzheimer’s disease in autopsy cases
ανά: Selma M. Soyal, κ.ά.
Έκδοση: (2020-08-01)

MRI Markers of Small Vessel Disease and the APOE Allele in Cognitive Impairment
ανά: Mana Shams, κ.ά.
Έκδοση: (2022-07-01)

The role of APOE in cognitive trajectories and motor decline in Parkinson’s disease
ανά: Sungyang Jo, κ.ά.
Έκδοση: (2021-04-01)

Resistance and resilience to tau pathology in Alzheimer's disease: Effects of age, sex, and APOE alleles
ανά: Yury Loika, κ.ά.
Έκδοση: (2024-10-01)

Rates of decline in Alzheimer disease decrease with age.
ανά: Dominic Holland, κ.ά.
Έκδοση: (2012-01-01)

Predicting cognitive decline in healthy older adults.
ανά: De Jager, C, κ.ά.
Έκδοση: (2005)

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
ανά: Belbin, O, κ.ά.
Έκδοση: (2009)

Dietary fats and the APOE-e4 risk allele in relation to cognitive decline: a longitudinal investigation in a biracial population sample
ανά: Xiaoran Liu, κ.ά.
Έκδοση: (2024-05-01)

Effect of APOE and CD33 on Cognitive Decline.
ανά: Kathleen M Hayden, κ.ά.
Έκδοση: (2015-01-01)

Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
ανά: Heather E. Dark, κ.ά.
Έκδοση: (2024-04-01)

Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease
ανά: Joseph Giorgio, κ.ά.
Έκδοση: (2020-01-01)

Selective effects of the APOE ε4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease
ανά: Mitchell K.P. Lai, κ.ά.
Έκδοση: (2006-06-01)

Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
ανά: Taizen Nakase, κ.ά.
Έκδοση: (2023-01-01)

Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease
ανά: Jagan A. Pillai, κ.ά.
Έκδοση: (2023-03-01)

Multimodal Discrimination between Normal Aging, Mild Cognitive Impairment and Alzheimer’s Disease and Prediction of Cognitive Decline
ανά: Corinna M. Bauer, κ.ά.
Έκδοση: (2018-02-01)

Structural Network Efficiency Predicts Resilience to Cognitive Decline in Elderly at Risk for Alzheimer’s Disease
ανά: Florian U. Fischer, κ.ά.
Έκδοση: (2021-02-01)

Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease
ανά: Jagan A. Pillai, κ.ά.
Έκδοση: (2020-07-01)

Correction: Effect of APOE and CD33 on Cognitive Decline.
ανά: Kathleen M Hayden, κ.ά.
Έκδοση: (2015-01-01)